Ways to help lessen the stress that can come with cancer treatments.
FDA Roundup: New Indication for Ayvakit, OTC Switch
A new indication, a nonprescription switch, a recall, and new guidances round out this week’s FDA news.
Read More
FDA Updates: Blood Cancers, Orphan Drug Designations Get Priority
In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.
Bringing Value to Cancer Care
How a tool is helping execs define and measure value in oncology.
Four Things to Know About Providing CAR T-Cell Treatment
Top oncology experts share how they deliver these therapies to patients in need.
How Immuno-Oncology Biomarkers Are Changing Cancer Care
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.
From MACRA to Burnout: How Oncologists Really Feel
New research from Cardinal Health Specialty Solutions has surprising findings about oncologists from meeting MACRA requirements to burnout.
